Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States
Cancer · 2026
DOI: 10.1002/cncr.70462 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2026. Verfasst von Lorenza Arena und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Colorectal Neoplasms, Early Detection of Cancer, Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Sexual orientation and gender identity (SOGI) minorities experience disparities in health care access and quality of care, however national evidence regarding adherence to recommended cancer screening remains limited. This study aimed to evaluate associations between SOGI status and adherence to US Preventive Services Task Force‐recommended colorectal, cervical, and breast cancer screening.
Methods
Adults eligible for colorectal (CRC; 45–74 years old), cervical (25–64 years old), or breast cancer (40–74 years old) screening were identified from the 2018–2022 Behavioral Risk Factor Surveillance System according to guideline‐concordant criteria. Respondents were categorized as sexual orientation minorities (SOM) versus heterosexual and as gender identity minorities (GIM) versus cisgender. Univariable results were reported as unweighted frequencies with survey‐weighted proportions. Survey‐weighted Poisson regression models were used to estimate adjusted prevalence ratios (aPRs) for screening adherence.
Results
Among 663,924 unweighted screening‐eligible respondents, weighted 1.2% ( n = 8108) identified as SOM and 0.4% ( n = 2315) as GIM; 33.5% ( n = 223,065) were assigned male at birth and 67.9% ( n = 522,845) identified as White. After adjustment for covariates, SOM was associated with lower adherence to cervical (aPR, 0.92; 95% CI, 0.87–0.97) and breast cancer screening (aPR, 0.84; 95% CI, 0.77–0.92) compared with heterosexual women. CRC screening adherence among SOM men was slightly higher (aPR, 1.10; 95% CI, 1.00–1.21). GIM status was associated with substantially lower adherence to cervical (aPR, 0.58; 95% CI, 0.37–0.90) and breast cancer screening (aPR, 0.24; 95% CI, 0.08–0.74) compared with cisgender respondents, with no difference in CRC screening ( p > .05).
Conclusions
Disparities in cervical and breast cancer screening persist among SOGI minorities. These findings underscore prevalent structural and systemic barriers in preventive cancer care and highlight the need for inclusive, culturally sensitive interventions to promote equitable screening access.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, USA.
ORCID-Profile: Odysseas P Chatzipanagiotou, Timothy M Pawlik
Zitieren
APA
Arena, L., Alizai, Q., Elemosho, A., Chatzipanagiotou, O. P., & Pawlik, T. M. (2026). Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States. Cancer. https://doi.org/10.1002/cncr.70462
Vancouver
Arena L, Alizai Q, Elemosho A, Chatzipanagiotou OP, Pawlik TM. Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States. Cancer. 2026. doi:10.1002/cncr.70462
BibTeX
@article{Arena2026,
author = {Arena, Lorenza and Alizai, Qaidar and Elemosho, Abdulaziz and Chatzipanagiotou, Odysseas P and Pawlik, Timothy M},
title = {Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States},
journal = {Cancer},
year = {2026},
doi = {10.1002/cncr.70462}
}
EUVIMED